scholarly journals Concomitant Infections of Influenza A H1N1 and Disseminated Cryptococcosis in an HIV Seropositive Patient

2015 ◽  
Vol 7 (02) ◽  
pp. 134-136 ◽  
Author(s):  
Ankit Gupta ◽  
Malini R Capoor ◽  
Sonal Gupta ◽  
Harish Chand Sachdeva
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
Unusual Case ◽  
Viral Infections ◽  
Dual Infection ◽  
Seropositive Patient ◽  
Seropositive Individual ◽  
Influenza A H1n1 ◽  
Respiratory Viral Infections ◽  
Hiv Seropositive

ABSTRACTRespiratory viral infections, especially influenza have a potential to form a fatal association with cryptococcosis in the setting of compromised immunity. Considering the lethality of these two infections, we report an unusual case of dual infection of pandemic influenza A H1N1 and disseminated cryptococcosis in an HIV seropositive individual.

scholarly journals ЕPIDEMIOLOGICAL AND СLINICAL FEATURES OF INFLUENZA IN CHILDREN IN THE STAVROPOL TERRITORY IN THE EPIDEMIC PERIOD OF 2015–2016 AND 2016–2017 YEARS

2019 ◽  
Vol 11 (1) ◽  
pp. 71-75
Author(s):  
S. M. Bezrodnova ◽  
N. A. Yatsenko ◽  
O. O. Kravchenko ◽  
Sh. M. Khurtsilava
Keyword(s):  
Specific Gravity ◽  
Influenza A ◽  
Viral Infections ◽  
Influenza B ◽  
Epidemic Season ◽  
Epidemiological Features ◽  
Influenza A H1n1 ◽  
Epidemic Period ◽  
Microcirculation Disturbance ◽  
Respiratory Viral Infections

Objective: to study the clinical and epidemiological features of influenza in children in the Stavropol Territory.Materials and methods: influenza prevalence is analyzed from 2015 to 2017 the paper used the data from the Territorial Rospotrebnadzor in the Stavropol Territory. We used the following methods: bibliographic, monographic description, epidemiological, analytical, statistical methods.Results: Among the deciphered acute respiratory viral infections, the specific gravity of influenza A (H1N1) 09 in 2016 reached 78%, and in 2017 influenza B prevailed – in 57,4% of children, and influenza A (H3N2) – in 42,6% of cases. In 2016 68,5% of children under 6 years of age, of all admitted, were hospitalized, and in 2017 – 83,86%. We presented the peculiarities of the course of influenza in different epidemic seasons.Conclusion: Unvaccinated children up to 6 years of age have the disease mainly in severe forms and with complications. The epidemic period began to increase in 2015–2016 at week 52, and in 2016–2017 from week 48, ended at week 13 and at week 17. At the epidemic of 2015–2016, intoxication syndrome with chills, microcirculation disturbance, catarrhal syndrome, ARDS prevailed in the clinical picture. The epidemic season of 2016–2017 was characterized by intoxication syndrome, encephalic reaction, hemorrhagic and myalgic syndromes.

scholarly journals Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections

Cells ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 3067
Author(s):  
Spiros Vlahopoulos ◽  
Ke Wang ◽  
Yaoyao Xue ◽  
Xu Zheng ◽  
Istvan Boldogh ◽  
...  
Keyword(s):  
Influenza A ◽  
Viral Infections ◽  
Clinical Care ◽  
Treatment Options ◽  
Pulmonary Complications ◽  
Epigenetic Mark ◽  
Host Immune System ◽  
Influenza A H1n1 ◽  
Respiratory Viral Infections ◽  
Syncytial Virus

The bronchial vascular endothelial network plays important roles in pulmonary pathology during respiratory viral infections, including respiratory syncytial virus (RSV), influenza A(H1N1) and importantly SARS-Cov-2. All of these infections can be severe and even lethal in patients with underlying risk factors.A major obstacle in disease prevention is the lack of appropriate efficacious vaccine(s) due to continuous changes in the encoding capacity of the viral genome, exuberant responsiveness of the host immune system and lack of effective antiviral drugs. Current management of these severe respiratory viral infections is limited to supportive clinical care. The primary cause of morbidity and mortality is respiratory failure, partially due to endothelial pulmonary complications, including edema. The latter is induced by the loss of alveolar epithelium integrity and by pathological changes in the endothelial vascular network that regulates blood flow, blood fluidity, exchange of fluids, electrolytes, various macromolecules and responses to signals triggered by oxygenation, and controls trafficking of leukocyte immune cells. This overview outlines the latest understanding of the implications of pulmonary vascular endothelium involvement in respiratory distress syndrome secondary to viral infections. In addition, the roles of infection-induced cytokines, growth factors, and epigenetic reprogramming in endothelial permeability, as well as emerging treatment options to decrease disease burden, are discussed.

scholarly journals Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1

2011 ◽  
Vol 38 (3) ◽  
pp. 739-742 ◽  
Author(s):  
M. A. Marcos ◽  
S. Ramon ◽  
A. Anton ◽  
E. Martinez ◽  
A. Vilella ◽  
...  
Keyword(s):  
Clinical Relevance ◽  
Influenza A ◽  
Viral Infections ◽  
Influenza A H1n1 ◽  
Respiratory Viral Infections

scholarly journals Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19

2021 ◽  
Author(s):  
José Alberto Choreño-Parra ◽  
Luis Armando Jiménez-Álvarez ◽  
Gustavo Ramírez-Martínez ◽  
Alfredo Cruz-Lagunas ◽  
Mahima Thapa ◽  
...  
Keyword(s):  
Pandemic Influenza ◽  
Influenza A ◽  
Alveolar Epithelium ◽  
Surfactant Protein ◽  
High Serum ◽  
Surfactant Protein D ◽  
Diagnostic Challenge ◽  
Moderate Disease ◽  
Influenza A H1n1 ◽  
Novel Biomarkers

Abstract The differentiation of influenza and COVID-19 could constitute a diagnostic challenge during the ongoing winter due to their clinical similitude. Thus, novel biomarkers that enable distinguishing both diseases are required. Here, we evaluated whether the surfactant protein D (SP-D), a collectin produced at the alveolar epithelium with known immune properties, was useful to differentiate pandemic influenza A(H1N1) from COVID-19 in critically ill patients. Our results revealed high serum SP-D levels in severe pandemic influenza but not COVID-19 patients. This finding was validated in a separate cohort of mechanically ventilated COVID-19 patients who also showed low plasma SP-D levels. However, plasma SP-D levels did not distinguish seasonal influenza from COVID-19 in mild-to-moderate disease. Finally, we found that high serum SP-D levels were associated with mortality and renal failure among severe pandemic influenza cases. Thus, our studies have identified SP-D as a unique biomarker expressed during severe pandemic influenza but not COVID-19.

scholarly journals Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Q. Sue Huang ◽  
◽  
Tim Wood ◽  
Lauren Jelley ◽  
Tineke Jennings ◽  
...  
Keyword(s):  
New Zealand ◽  
Pandemic Influenza ◽  
Viral Infections ◽  
Surveillance Systems ◽  
Respiratory Viral Infections ◽  
Nonpharmaceutical Interventions

AbstractStringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020. This finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.

Sign in / Sign up

Export Citation Format

Share Document